PMDA — authorised 22 November 2022
- Marketing authorisation holder: Shionogi & Co., Ltd.
- Status: approved
PMDA authorised Xocova on 22 November 2022
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Yes. PMDA authorised it on 22 November 2022; PMDA has authorised it.
Shionogi & Co., Ltd. holds the Japanese marketing authorisation.